Displaying 1–25 of 104 results for Emil W. Ciurczak
Small, real-time measurements make large contributions to process analytical technology
A review of IFPAC Annual Meeting 2018 from contributing editor Emil W. Ciurczak.
Interviews with product experts about select hardware/software products applicable to PAT/QbD, highlighting key features of each instrument/program
Hand-made to assembly lines, now, to automated production
A new attitude was clearly on display at IFPAC 2017
CPhI Worldwide's 2017 Pharma Predictions: The Good, the Bad, and the Donald. Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities.
Trends include continuous manufacturing, biosimilars, supply chain security and smaller instrumentation
There are a number of points of view and opinions on how good or necessary biosimilars actually are
Packaging does much more than serve as a place for the label
Why so many pharmaceutical companies can’t “just do” PAT
International Conference on Harmonization represents the countries interested in unified standards
Or, what have we forgotten?
Neither rain, nor sleet, nor snow could keep me from finding the lastest technology at IFPAC 2016 conference.
The Continuous Manufacturing (CM) program at Rutgers University continues
What can a PAT program bring to the packaging party?
Instrument and PAT vendors are continually innovating, unveiling new systems or significant new features at PittCon
Instrument and PAT vendors are continually innovating, and 2015 is no different
The quest for “knowing exactly what’s in the soup”
PAT groups must improvise when validating a process analysis. In many cases, several metrics are not based on current practices
Complexity and lean staff often create a non-compliant operational culture; fortunately there are ways to fight the malaise
U.S. regulators want more than release tests to prove biosimilar safety and efficacy
Time, space, utilities and labor ARE all saved by using continuous manufacturing in lieu of current production methods.
Newer monitoring technologies can provide real insight into solid-dose forms in process
Efficiencies from well applied PAT and QbD principles have the potential to re-align orphan drug cost structures
CPhI Conferences announces a three-day technical conference, Quality by Design, taking place from 25 - 27 November 2013 in Kuala Lumpur, Malaysia.